Check this out >>> The top ten global generic drug manufacturers and distributors account for approximately 66% of the market. Doug Long, vice-president, industry relations at IMS Health recently stated, “This means there are still many players out there that are pretty small and would be ripe for acquisitions or mergers…Everybody expects that there will be consolidation within the generic drugs industry…”